Nikoletta Fotaki
Nikoletta Fotaki
Reader in Biopharmaceutics, University of Bath, UK
Bestätigte E-Mail-Adresse bei bath.ac.uk - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects
M Vertzoni, N Fotaki, E Nicolaides, C Reppas, E Kostewicz, E Stippler, ...
Journal of pharmacy and pharmacology 56 (4), 453-462, 2004
2382004
Biorelevant dissolution methods and their applications in in vitro-in vivo correlations for oral formulations
N Fotaki, M Vertzoni
The Open Drug Delivery Journal 4 (1), 2010
992010
Paediatric oral biopharmaceutics: key considerations and current challenges
HK Batchelor, N Fotaki, S Klein
Advanced drug delivery reviews 73, 102-126, 2014
902014
Flow-through cell apparatus (USP apparatus 4): operation and features
N Fotaki
Dissolution Technol 18 (4), 46-49, 2011
762011
A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations
N Fotaki, A Aivaliotis, J Butler, J Dressman, M Fischbach, J Hempenstall, ...
European journal of pharmaceutics and biopharmaceutics 73 (1), 115-120, 2009
732009
Predictive models for oral drug absorption: from in silico methods to integrated dynamical models
A Dokoumetzidis, L Kalantzi, N Fotaki
Expert opinion on drug metabolism & toxicology 3 (4), 491-505, 2007
632007
Biorelevant dissolution: methodology and application in drug development
Q Wang, N Fotaki, Y Mao
Dissolution Technol 16 (3), 6-12, 2009
622009
In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis
N Fotaki, M Symillides, C Reppas
European journal of pharmaceutical sciences 24 (1), 115-122, 2005
612005
Canine versus in vitro data for predicting input profiles of l-sulpiride after oral administration
N Fotaki, M Symillides, C Reppas
European journal of pharmaceutical sciences 26 (3-4), 324-333, 2005
502005
Pharmaceutical characterisation and evaluation of cocrystals: importance of in vitro dissolution conditions and type of coformer
I Tomaszewska, S Karki, J Shur, R Price, N Fotaki
International journal of pharmaceutics 453 (2), 380-388, 2013
492013
Biopharmaceutical aspects and implications of excipient variability in drug product performance
P Zarmpi, T Flanagan, E Meehan, J Mann, N Fotaki
European Journal of Pharmaceutics and Biopharmaceutics 111, 1-15, 2017
452017
The flow through cell methodology in the evaluation of intralumenal drug release characteristics
N Fotaki, C Reppas
Dissolution Technol 12 (2), 17-21, 2005
422005
Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation
A Taverner, R Dondi, K Almansour, F Laurent, SE Owens, IM Eggleston, ...
Journal of Controlled Release 210, 189-197, 2015
412015
Assessment of age-related changes in pediatric gastrointestinal solubility
AR Maharaj, AN Edginton, N Fotaki
Pharmaceutical research 33 (1), 52-71, 2016
292016
BU08073 a buprenorphine analogue with partial agonist activity at μ‐receptors in vitro but long‐lasting opioid antagonist activity in vivo in mice
TV Khroyan, J Wu, WE Polgar, G Cami‐Kobeci, N Fotaki, SM Husbands, ...
British journal of pharmacology 172 (2), 668-680, 2015
282015
Intestinal permeability and excretion into bile control the arrival of amlodipine into the systemic circulation after oral administration
D Raušl, N Fotaki, R Zanoški, M Vertzoni, B Cetina‐Čižmek, MZI Khan, ...
Journal of pharmacy and pharmacology 58 (6), 827-836, 2006
232006
Oral drug absorption in pediatric populations
AN Edginton, N Fotaki
Oral drug absorption: prediction and assessment, 108-126, 2010
222010
Fed-state gastric media and drug analysis techniques: Current status and points to consider
F Baxevanis, J Kuiper, N Fotaki
European Journal of Pharmaceutics and Biopharmaceutics 107, 234-248, 2016
202016
Small-scale assays for studying dissolution of pharmaceutical cocrystals for oral administration
KJ Box, J Comer, R Taylor, S Karki, R Ruiz, R Price, N Fotaki
AAPS PharmSciTech 17 (2), 245-251, 2016
202016
Impact of gastrointestinal disease states on oral drug absorption–implications for formulation design–a PEARRL review
A Effinger, CM O'Driscoll, M McAllister, N Fotaki
Journal of Pharmacy and Pharmacology 71 (4), 674-698, 2019
192019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20